20 studies found for:    S0802
Show Display Options
Rank Status Study
1 Unknown  Sterimar vs Saline Sprays in Nasal Surgical Aftercare - a Blinded, Randomised Trial
Condition: Nasal Surgery
Interventions: Drug: Sterimar Spray;   Drug: Generic homemade nasal saline spray (salt and water)
2 Active, not recruiting Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Conditions: Extensive Stage Small Cell Lung Cancer;   Recurrent Small Cell Lung Cancer
Interventions: Biological: ziv-aflibercept;   Drug: topotecan hydrochloride
3 Recruiting Biomarkers of Bone Resorption in Metastatic Prostate Cancer
Condition: Metastatic Prostate Cancer
4 Completed Nuclear Magnetic Resonance Therapy in Knee Osteoarthrosis
Condition: Osteoarthrosis
Interventions: Device: MRI therapy;   Device: MRI therapy (off)
5 Completed A Pilot Study of the Effects of Isotretinoin on Cognition, Learning and Memory
Condition: Acne Vulgaris
Intervention: Drug: Isotretinoin
6 Recruiting Study of Oral Anthocyanins on Insulin Resistance
Condition: Type 2 Diabetes
Intervention: Dietary Supplement: Mirtoselect
7 Completed Osteocel® Plus in Anterior Cervical Discectomy and Fusion (ACDF)
Condition: Degenerative Disc Disease in Cervical Spine
Intervention: Biological: Biologic - Osteocel Plus
8 Unknown  Comparison of Pressure Support and Pressure Control Ventilation in Chronic Respiratory Failure
Conditions: COPD;   Chest Wall Disease;   Neuromuscular Disease;   Obesity Hypoventilation
Interventions: Other: Pressure support ventilation;   Other: Pressure control ventilation
9 Terminated
Has Results
Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases)
Conditions: Type 2 Diabetes Mellitus;   Cardiovascular Disease
Interventions: Drug: Aliskiren;   Drug: Placebo
10 Completed Effectiveness of the Pelican Instrument in Medical Care
Condition: Asthma
Interventions: Other: PELICAN Primary Care;   Other: PELICAN Secondary Care
11 Completed
Has Results
Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.
Condition: Cardiovascular Diseases
Interventions: Drug: Telmisartan;   Drug: Combination of Telmisartan and Ramipril;   Drug: Ramipril
12 Active, not recruiting A Study of RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25305)
Condition: Schizophrenia
Interventions: Drug: bitopertin [RO4917838];   Drug: Placebo
13 Suspended Safety and Efficacy of Talactoferrin Alfa in Patients With Severe Sepsis
Condition: Severe Sepsis
Interventions: Drug: Talactoferrin alfa;   Drug: Placebo
14 Completed Compact Closed System Versus Mounted Open System (COSMOS)
Condition: Catheterization, Peripheral
Interventions: Device: Open Intravenous System - Vasocan®;   Device: Closed Intravenous System - Nexiva®
15 Recruiting Phase I Trial of Oral Metronomic Topotecan and Oral Pazopanib to Treat Recurrent/Persistent Gynecologic Tumors
Condition: Gynecologic Tumors
Interventions: Drug: Oral Topotecan;   Drug: Pazopanib
16 Completed
Has Results
Evaluation of the Long- Term Effects of Spiriva on Lung Function in COPD Patients
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium;   Drug: placebo
17 Active, not recruiting A Study of RO4917838 (Bitopertin) in Patients With Persistent, Predominant Negative Symptoms of Schizophrenia (WN25308)
Condition: Schizophrenia
Interventions: Drug: Placebo;   Drug: bitopertin [RO4917838]
18 Recruiting Proton Therapy With Chemotherapy for Stage III Non-Small Cell Lung Cancer (LU02)
Condition: Non-Small Cell Lung Cancer
Interventions: Radiation: PET positive nodal disease measuring 15 mm or greater;   Radiation: PET positive nodal disease measuring less than 15 mm;   Radiation: Patients considered resectable
19 Unknown  Consolidation PET-based and Donor-based After Salvage Therapy in Patients With Hodgkin Lymphoma in Relapse or Refractory
Condition: Hodgkin's Lymphoma
Interventions: Other: Patients with negative PET after salvage therapy;   Other: Patients with positive PET after salvage therapy
20 Completed
Has Results
Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
Conditions: Atrial Fibrillation;   Stroke
Interventions: Drug: warfarin;   Drug: Dabigatran dose 1;   Drug: Dabigatran dose 2

Indicates status has not been verified in more than two years